Acadian Asset Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-135,324
Closed -$249K 1970
2023
Q1
$249K Sell
135,324
-962,504
-88% -$1.77M ﹤0.01% 1212
2022
Q4
$1.22M Buy
1,097,828
+298,443
+37% +$331K 0.01% 800
2022
Q3
$1.87M Sell
799,385
-21,942
-3% -$51.3K 0.01% 657
2022
Q2
$2.49M Buy
821,327
+2,974
+0.4% +$9.01K 0.01% 574
2022
Q1
$5.56M Sell
818,353
-76,871
-9% -$522K 0.02% 444
2021
Q4
$7.47M Buy
895,224
+6,859
+0.8% +$57.3K 0.03% 360
2021
Q3
$6.6M Buy
888,365
+184,446
+26% +$1.37M 0.03% 394
2021
Q2
$4.79M Buy
703,919
+218,774
+45% +$1.49M 0.02% 477
2021
Q1
$4.98M Sell
485,145
-67,483
-12% -$693K 0.02% 478
2020
Q4
$3.87M Sell
552,628
-302,494
-35% -$2.12M 0.02% 576
2020
Q3
$6.98M Sell
855,122
-114,562
-12% -$935K 0.03% 375
2020
Q2
$6.69M Buy
969,684
+11,267
+1% +$77.7K 0.03% 417
2020
Q1
$4.55M Buy
958,417
+278,939
+41% +$1.32M 0.03% 414
2019
Q4
$5.93M Buy
679,478
+259,817
+62% +$2.27M 0.03% 402
2019
Q3
$1.4M Buy
419,661
+43,571
+12% +$145K 0.01% 795
2019
Q2
$1.86M Buy
376,090
+84,557
+29% +$419K 0.01% 644
2019
Q1
$1.81M Buy
291,533
+151,576
+108% +$940K 0.01% 715
2018
Q4
$471K Buy
139,957
+79,266
+131% +$267K ﹤0.01% 917
2018
Q3
$395K Buy
60,691
+38,086
+168% +$248K ﹤0.01% 932
2018
Q2
$173K Sell
22,605
-64,297
-74% -$492K ﹤0.01% 1123
2018
Q1
$1.94M Sell
86,902
-157,054
-64% -$3.51M 0.01% 593
2017
Q4
$3.11M Sell
243,956
-73,291
-23% -$935K 0.01% 463
2017
Q3
$4.94M Buy
317,247
+149,048
+89% +$2.32M 0.02% 371
2017
Q2
$2.36M Buy
+168,199
New +$2.36M 0.01% 542